These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 17085341

  • 1. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B, Ye T, Zhao L, Li DH, Gou XH, Zhao LY, Han L, Chen L, Yan LN, Gong JP.
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [Abstract] [Full Text] [Related]

  • 2. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN.
    Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188
    [Abstract] [Full Text] [Related]

  • 3. [Reversal of multidrug resistance gene MDR1 and MRP of drug-resistant human hepatocellular carcinoma cells SMMC-7721/ADM with antisense phosphorothioate oligonucleotides].
    Luo HY, Yang JY, Liu ZM, Lin QY, Yan LN.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb 20; 12(2):85-7. PubMed ID: 14980107
    [Abstract] [Full Text] [Related]

  • 4. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
    Li Y, Wang Y.
    Biochem Biophys Res Commun; 1997 Oct 09; 239(1):345-8. PubMed ID: 9345322
    [Abstract] [Full Text] [Related]

  • 5. Construction of the recombinant adenovirus vector carrying antisense multidrug resistance gene.
    Li B, Gou XH, Chen L, Li DH, Zhao YH, Han L, Zhao LY, Gong JP.
    Hepatobiliary Pancreat Dis Int; 2006 Feb 09; 5(1):80-4. PubMed ID: 16481289
    [Abstract] [Full Text] [Related]

  • 6. [Reversal of the multidrug resistance in human hepatocellular carcinoma cells by recombinant adenoviral delivery of the MRP antisense RNA in vitro].
    Chen L, Yan LN, Gou XH, Li DH, Han L.
    Zhonghua Yi Xue Za Zhi; 2005 Oct 12; 85(38):2719-23. PubMed ID: 16324302
    [Abstract] [Full Text] [Related]

  • 7. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
    Yang JY, Luo HY, Lin QY, Liu ZM, Yan LN, Lin P, Zhang J, Lei S.
    World J Gastroenterol; 2002 Aug 12; 8(4):644-9. PubMed ID: 12174371
    [Abstract] [Full Text] [Related]

  • 8. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N.
    Chin Med J (Engl); 2001 Sep 12; 114(9):929-32. PubMed ID: 11780384
    [Abstract] [Full Text] [Related]

  • 9. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, Piao SL, Du ZW, Gao S, Zheng DM.
    Chin Med J (Engl); 2005 Jun 05; 118(11):893-902. PubMed ID: 15978189
    [Abstract] [Full Text] [Related]

  • 10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 05; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 11. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes.
    Huesker M, Folmer Y, Schneider M, Fulda C, Blum HE, Hafkemeyer P.
    Hepatology; 2002 Oct 05; 36(4 Pt 1):874-84. PubMed ID: 12297834
    [Abstract] [Full Text] [Related]

  • 12. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
    Wei HL, Wu YJ, Jing T, Bai DC, Ma LF.
    Acta Pharmacol Sin; 2003 Aug 05; 24(8):805-11. PubMed ID: 12904281
    [Abstract] [Full Text] [Related]

  • 13. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
    Sun BT, Zheng LH, Bao YL, Yu CL, Wu Y, Meng XY, Li YX.
    Eur J Pharmacol; 2011 Mar 05; 654(2):129-34. PubMed ID: 21195709
    [Abstract] [Full Text] [Related]

  • 14. [An experimental study of recombinant adenovirus microsphere carrying antisense multidrug resistance-associated protein gene for reversing MRP of hepatocellular carcinoma in vitro].
    Yu SH, Yan LN, Zhang Y, Gou XH, Han L, Chen YB.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul 05; 36(4):471-4. PubMed ID: 16078563
    [Abstract] [Full Text] [Related]

  • 15. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P, Zhou GY, Lei DP, Zhang XF, Li L, Xu JW, Lin XY.
    Cytotherapy; 2007 Jul 05; 9(8):795-801. PubMed ID: 17917879
    [Abstract] [Full Text] [Related]

  • 16. [Reversal of adriamycin resistance of hepatocellular carcinoma by targeting it with recombined adenovirus carrying antisense multidrug resistance gene 1 RNA].
    Mei Y, Shi YJ, Ding X, Wu CX, Jian HG, Gong JP, Liu CA.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar 05; 15(3):199-203. PubMed ID: 17407711
    [Abstract] [Full Text] [Related]

  • 17. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
    Zhu L, Lang J, Shen K.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug 05; 32(8):462-6. PubMed ID: 9639738
    [Abstract] [Full Text] [Related]

  • 18. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
    Gao P, Zhou GY, Guo LL, Zhang QH, Zhen JH, Fang AJ, Lin XY.
    Cancer Lett; 2007 Oct 18; 256(1):81-9. PubMed ID: 17637500
    [Abstract] [Full Text] [Related]

  • 19. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 Oct 18; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 20. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G, Dong S, Qu J, Sun Z, Huang Z, Ye L, Liang H, Ai X, Zhang W, Chen X.
    Liver Int; 2010 Apr 18; 30(4):585-92. PubMed ID: 19780956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.